Zaeske Adam H. — SEC Form 4 filings

SEC reporting owner CIK 2064712. 3 Form 4 filings on record with FilingPulse; latest filed 2026-04-09.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2025-04-16 to 2026-04-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Harmony Biosciences Holdings, Inc. (HRMY)CHIEF COMMERCIAL OFFICER37

Form 4 filings — Zaeske Adam H.

FiledFormIssuerReported transactionsSource
2026-04-094Harmony Biosciences Holdings, Inc. (HRMY)Option exercise (M): 7,500 @ $0 · Tax withholding (F): 3,173 @ $27.62 · Option exercise (M): 7,500 (derivative) @ $0EDGAR
2026-01-264Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 56,900 (derivative) @ $0 · Grant/award (A): 16,200 (derivative) @ $0EDGAR
2025-04-164Harmony Biosciences Holdings, Inc. (HRMY)Grant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2064712 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →